These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 10703933

  • 1. Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss.
    Salamone LM, Cauley JA, Zmuda J, Pasagian-Macaulay A, Epstein RS, Ferrell RE, Black DM, Kuller LH.
    J Bone Miner Res; 2000 Feb; 15(2):308-14. PubMed ID: 10703933
    [Abstract] [Full Text] [Related]

  • 2. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study.
    Schoofs MW, van der Klift M, Hofman A, van Duijn CM, Stricker BH, Pols HA, Uitterlinden AG.
    J Bone Miner Res; 2004 Sep; 19(9):1490-6. PubMed ID: 15312249
    [Abstract] [Full Text] [Related]

  • 3. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
    MacDonald HM, McGuigan FA, New SA, Campbell MK, Golden MH, Ralston SH, Reid DM.
    J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
    [Abstract] [Full Text] [Related]

  • 4. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Sep; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 5. Osteoporosis and apolipoprotein E genotype in older adults: the Rancho Bernardo study.
    von Mühlen DG, Barrett-Connor E, Schneider DL, Morin PA, Parry P.
    Osteoporos Int; 2001 Sep; 12(4):332-5. PubMed ID: 11420784
    [Abstract] [Full Text] [Related]

  • 6. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
    Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH.
    J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
    [Abstract] [Full Text] [Related]

  • 7. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
    Yoshimura N, Kasamatsu T, Sakata K, Hashimoto T, Cooper C.
    J Bone Miner Metab; 2002 Feb; 20(5):303-10. PubMed ID: 12203037
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk--The Study of Osteoporotic Fractures.
    Cauley JA, Zmuda JM, Yaffe K, Kuller LH, Ferrell RE, Wisniewski SR, Cummings SR.
    J Bone Miner Res; 1999 Jul; 14(7):1175-81. PubMed ID: 10404018
    [Abstract] [Full Text] [Related]

  • 9. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
    Morita A, Iki M, Dohi Y, Ikeda Y, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F, JPOS Study Group.
    Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women.
    Efstathiadou Z, Koukoulis G, Stakias N, Challa A, Tsatsoulis A.
    Maturitas; 2004 Jul 15; 48(3):259-64. PubMed ID: 15207892
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study.
    Garnero P, Borel O, Sornay-Rendu E, Arlot ME, Delmas PD.
    J Bone Miner Res; 1996 Jun 15; 11(6):827-34. PubMed ID: 8725180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J.
    J Bone Miner Res; 1999 Sep 15; 14(9):1583-95. PubMed ID: 10469288
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
    Heikkinen AM, Niskanen LK, Salmi JA, Koulu M, Pesonen U, Uusitupa MI, Komulainen MH, Tuppurainen MT, Kröger H, Jurvelin J, Saarikoski S.
    Bone; 2004 Sep 15; 35(3):589-94. PubMed ID: 15336593
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.